What every intensivist should know about Tocilizumab – Critical Care Related: Tocilizumab in COVID-19 therapy: who benefits, and how? A living WHO guideline on drugs for covid-19 – interleukin-6 receptor blockers are now recommended for patients with severe or critical covid-19. M-A: Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 […]

The post What every intensivist should know about Tocilizumab. appeared first on Links Medicus.